Short Interest in National Research Co. (NASDAQ:NRC) Drops By 14.7%

National Research Co. (NASDAQ:NRC - Get Free Report) saw a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 344,700 shares, a decrease of 14.7% from the April 30th total of 404,200 shares. Based on an average daily volume of 98,900 shares, the short-interest ratio is currently 3.5 days. Approximately 2.7% of the company's stock are sold short.

Insider Buying and Selling at National Research

In other National Research news, major shareholder Patrick E. Beans bought 2,500 shares of the stock in a transaction dated Monday, May 12th. The shares were acquired at an average cost of $13.59 per share, for a total transaction of $33,975.00. Following the completion of the transaction, the insider now owns 35,003 shares in the company, valued at approximately $475,690.77. The trade was a 7.69% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 8.10% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Inspire Investing LLC raised its stake in shares of National Research by 16.5% during the 1st quarter. Inspire Investing LLC now owns 26,739 shares of the company's stock worth $342,000 after buying an additional 3,787 shares during the last quarter. Rhumbline Advisers raised its stake in shares of National Research by 4.5% during the 1st quarter. Rhumbline Advisers now owns 22,204 shares of the company's stock worth $284,000 after buying an additional 946 shares during the last quarter. Strs Ohio acquired a new position in shares of National Research during the 1st quarter worth $33,000. Jane Street Group LLC increased its position in National Research by 394.2% during the 1st quarter. Jane Street Group LLC now owns 52,411 shares of the company's stock worth $671,000 after purchasing an additional 41,806 shares in the last quarter. Finally, AQR Capital Management LLC increased its position in National Research by 168.6% during the 1st quarter. AQR Capital Management LLC now owns 108,134 shares of the company's stock worth $1,384,000 after purchasing an additional 67,882 shares in the last quarter. Institutional investors and hedge funds own 47.26% of the company's stock.

National Research Stock Performance

Shares of NASDAQ NRC traded up $0.65 during mid-day trading on Friday, hitting $15.02. 108,126 shares of the company were exchanged, compared to its average volume of 96,448. National Research has a 1-year low of $9.76 and a 1-year high of $27.07. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30. The stock has a 50 day simple moving average of $12.52 and a 200-day simple moving average of $15.34. The firm has a market cap of $342.23 million, a price-to-earnings ratio of 14.30 and a beta of 0.34.

National Research (NASDAQ:NRC - Get Free Report) last released its earnings results on Monday, April 28th. The company reported $0.25 EPS for the quarter. The company had revenue of $33.55 million during the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 3.20%. The ex-dividend date is Friday, June 27th. National Research's dividend payout ratio (DPR) is presently 46.60%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.